Edap TMSFOCL +1.91%53 EV-to-FCF is -10.40 as of Jun. 24, 2026. GuruFocus rates FOCL with a GF Score™ of 53/100 and a GF Value™ of $4.52 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 76 Medical Distribution companies, Edap TMS ranks worse than 1315788.16% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Edap TMS's Enterprise Value is $203.0 Mil.
Edap TMS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-19.5 Mil. Therefore, Edap TMS's EV-to-FCF for today is -10.40.
The historical rank and industry rank for Edap TMS's EV-to-FCF or its related term are showing as below:
FOCL'
s EV-to-FCF Range Over the Past 10 Years
Min: -7548.85 Med: -5.97 Max: 1551.52
Current: -10.4
During the past 13 years, the highest EV-to-FCF of Edap TMS was 1551.52. The lowest was -7548.85. And the median was -5.97.
FOCL's EV-to-FCF is ranked worse than 100% of 76
companies
in the Medical Distribution industry
Industry Median: 16.505
vs FOCL: -10.40
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Edap TMS's share price for today is $5.075.
Edap TMS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.827.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Edap TMS EV-to-FCF Related Terms
Edap TMS EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Edap TMS's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Edap TMS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edap TMS EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Edap TMS's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Edap TMS's EV-to-FCF falls into.
Edap TMS's current Enterprise Value is $203.0 Mil.
Edap TMS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edap TMS (FOCL) has a EV-to-FCF of -10.40 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Edap TMS and its competitors. According to the industry distribution chart, Edap TMS ranks #999999 out of 76 companies in the Medical Distribution industry.
Is Edap TMS's EV-to-FCF too high?
Edap TMS's current EV-to-FCF is -10.40. Based on the distribution chart, Edap TMS ranks #999999 out of 76 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Edap TMS has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Edap TMS's EV-to-FCF compare to ACH and YI?
According to the Medical Distribution industry distribution chart, Edap TMS ranks #999999 out of 76 companies for EV-to-FCF. This places Edap TMS in the lower half of its industry. The industry median EV-to-FCF is 16.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.51, based on 76 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Edap TMS and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edap TMS's current EV-to-FCF is -10.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edap TMS stock overvalued right now?
Based on GuruFocus' analysis, Edap TMS (FOCL) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.52, compared to a current price of $5.08 — trading 12.3% above its estimated fair value. The current EV-to-FCF is -10.40. Edap TMS's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Edap TMS (FOCL), the current EV-to-FCF is -10.40 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Edap TMS (FOCL) Overvalued in 2026?
Based on GuruFocus' analysis, Edap TMS stock appears to be overvalued.
The current stock price of $5.08 is trading 12.3% above its estimated GF Value™ of $4.52.
GuruFocus considers Edap TMS to be Modestly Overvalued.
Key valuation signals for FOCL:
EV-to-FCF: -10.40
GF Value™: $4.52 vs. price of $5.08 (12.3% above fair value)
No single metric tells the full story. See the FOCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
53GF Score
Get the complete analysis for FOCL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FOCL has been successfully added to your 
